CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Sep. 30, 2017	Dec. 31, 2016
Current assets
Cash	$ 4,623	$ 9,375
Prepaid drug product for testing	653	376
Other current assets	511	902
Total current assets	5,787	10,653
Fixed assets
Furniture, fixtures & equipment	999	708
Less accumulated depreciation	(279)	(94)
Property, Plant and Equipment, Net	720	614
Other assets
Technology licenses	2,500	2,500
Less accumulated amortization	(1,691)	(1,571)
Intangible Assets, Net (Excluding Goodwill), Total	809	929
Total Assets	7,316	12,196
Current liabilities
Accounts payable	121	69
Accrued expenses	634	969
Deferred revenue	12	12
Total current liabilities	767	1,050
Warrant liability	0	2,906
Total Liabilities	767	3,956
Shareholders' equity
Preferred stock, $.001 par value; 10,000 shares authorized; no shares issued and outstanding	0	0
Common stock, $.001 par value; 200,000 shares authorized; 100,057 and 95,645 shares issued and outstanding, respectively	100	96
Additional paid in capital	43,439	40,278
Accumulated deficit	(36,990)	(32,134)
Total shareholders' equity	6,549	8,240
Total Liabilities & Shareholders' Equity	$ 7,316	$ 12,196